Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Quality over quantity: the importance of collecting relevant samples to understand complex diseases

Alen Faiz, Maarten van den Berge
European Respiratory Journal 2022 59: 2200418; DOI: 10.1183/13993003.00418-2022
Alen Faiz
1University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, Sydney, Australia
2University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands
3University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten van den Berge
2University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands
3University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

When investigating the mechanisms behind heterozygous diseases such as COPD, collecting and sequencing samples and comparing it back to histology can help find new insights into the development of disease. https://bit.ly/3CV49O1

Whole transcriptional studies investigating COPD have provided important insights into the development and progression of this complex disease. These have ranged from transcriptome studies on easily accessible samples like blood, induced sputum and nasal epithelial brushes [1], to those that are more invasive and difficult to collect, such as bronchial biopsies and brushes [2, 3], or lung tissue [4, 5], which usually requires tissue derived from transplant donors or lung cancer resection. Lung tissue is considered one of the most relevant samples to COPD due to the nature and location of parenchymal tissue destruction. However, the heterogeneity of the disease, not only between patients but also within a single individual, makes interpretation of the results more difficult. In the article by Feng et al. [6] in the current issue of the European Respiratory Journal, the authors show that the loss of terminal bronchioles in COPD occurs in so-called “hot spots”, which are areas with a linear mean intercept between 500 and 1000 µm. Transcriptional profiling of lung tissue from these hot spots using “regional transcriptomics” identified an 11 gene signature associated with upregulation of IFNG signalling, co-stimulatory immune checkpoint genes, and genes related to the inflammasome pathway. Regional transcriptomics is a method where multiple samples are taken from the same patient, and matching histology is collected from samples that are sequenced. This method allows for histological features to be linked to transcriptomic profiles and potentially helps to identify the genes and mechanism behind these features (figure 1a).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Overview of the methods to measure spatial information in tissue samples. a) Types of RNA sequencing and their ability to retain spatial information. b) U-map of parenchyma samples (n=6) displaying the expression of the 11 gene “hot spot” signature.

Previous large studies comparing COPD lung tissue to non-COPD lung tissue have not found the 11 genes to be significant between the two groups or COPD disease severity [5]. A possible explanation for the fact that this signature was not found to reflect COPD or COPD disease severity may be the lack of data on regional emphysema severity. The data provided by Feng et al. [6] indicate that this information should be taken into account in future studies collecting lung tissue samples. Identifying gene expression changes associated with regional emphysema severity is not a new concept, with Campbell et al. [7] identifying 127 genes that were significantly associated with regional emphysema severity. This study differed from Feng et al. [6] as it focused solely on the degree of emphysema and not on the loss of terminal bronchioles. As could be expected, no overlap between the signatures derived from the two studies was observed. One thing to note is that regional transcriptional studies tend to suffer from power issues as they usually require multiple samples from each patient, with Campbell et al. [7] only having two healthy individuals and six patients with COPD.

Feng et al. [6] also used cellular deconvolution through a program known as CIBERSORT [8], to determine the inflammatory cell infiltration into the “hot spots”. This method determines the percentages of certain cell types in a given sample based on the expression of marker genes unique to the cell types being tested, and has be previously used to determine the composition of bronchial biopsies [9]. Using this method, they found that CD4, CD8, and B cell lymphocytes were infiltrating the hotspots. This nicely links to a previous report that found the severity of emphysema measured by parametric response mapping was associated with higher levels of CXCL11 expression in the airways, which is a potent chemokine involved in CD8+ T cell activation [10]. To verify their findings, Feng et al. [6] used serial sections from the same region that they sequenced, so that they were able to verify gene expression changes in inflammatory cells by immunohistochemistry. Cellular deconvolution together with regional transcriptomics is a powerful combination to identify and verify changes in cellular composition in a region-based analysis.

Single-cell sequencing (sc-Seq) analysis provides a profile of the transcriptome for each individual cell and offers another method to overcome the heterogeneity of lung tissue samples. Sc-Seq studies of COPD parenchyma are limited but have identified a subpopulation of alveolar epithelial type II cells that based on transcriptomic data was predicted to have reduced cellular stress tolerance in COPD [11]. This finding would not have been elucidated with bulk RNA-Seq, which carries a large amount of noise due to differences in cellular composition. In the context of the findings of Feng et al. [6], this reduced cellular stress tolerance may extend to the terminal bronchioles. Interestingly, taking the 11 gene signature and applying it to sc-Seq data from parenchyma (n=6) [12], we see that this signature is mainly expressed in neutrophils, dendritic cells and luminal macrophages (figure 1b). The latter nicely matches their finding of increased M1 macrophages in their “hot spot” region. A drawback of sc-Seq is that it involves dissociation of cells during sample processing; therefore, linking the cells back to their original locations has been challenging. Interestingly, recent sequencing advances have led to a method to overcome this dissociation issue. Spatial transcriptomics is a method of performing RNA sequencing directly on tissue sections, allowing the cellular structure to be linked to transcriptomic profiles. This technology has yet to be used in COPD; however, it has been suggested that it will move the field forward and has been nicely explained in a recent review by Curras-Alonso et al. [13].

One of the main findings of Feng et al. [6] is that terminal bronchioles are destroyed within regions of microscopic emphysematous destruction with an average airspace size of ≥500 and <1000 μm in COPD. This provides some molecular mechanism behind the observation that the destruction of the terminal bronchioles precedes the onset of emphysematous destruction measured by micro-computed tomography and the destruction of the terminal bronchioles [14].

In conclusion, spatial and regional transcriptional studies provide a promising new tool for developing clinically relevant biomarkers for the development of emphysema and provide novel treatment targets that could lead to improved personalised treatment of this disease. Feng et al. [6] provide one of the first well-powered studies to investigate this transcriptional spatial information.

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-00418-2022.Shareable

Footnotes

  • Conflict of interest: All authors have nothing to disclose.

  • Received February 25, 2022.
  • Accepted March 3, 2022.
  • Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org
https://www.ersjournals.com/user-licence

References

  1. ↵
    1. Boudewijn IM,
    2. Faiz A,
    3. Steiling K, et al.
    Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression. Respir Res 2017; 18: 213. doi:10.1186/s12931-017-0696-5
    OpenUrlCrossRefPubMed
  2. ↵
    1. Becker EJ,
    2. Faiz A,
    3. van den Berge M, et al.
    Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD. Thorax 2022; 77: 31–39. doi:10.1136/thoraxjnl-2019-214476
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Steiling K,
    2. van den Berge M,
    3. Hijazi K, et al.
    A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med 2013; 187: 933–942. doi:10.1164/rccm.201208-1449OC
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Spira A,
    2. Beane J,
    3. Pinto-Plata V, et al.
    Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol 2004; 31: 601–610. doi:10.1165/rcmb.2004-0273OC
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Brandsma C-A,
    2. van den Berge M,
    3. Postma DS, et al.
    A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Thorax 2015; 70: 21–32. doi:10.1136/thoraxjnl-2014-205091
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Xu F,
    2. Vasilescu DM,
    3. Kinose D, et al.
    The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD. Eur Respir J 2022; 59: 2101411. doi:10.1183/13993003.01411-2021
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Campbell JD,
    2. McDonough JE,
    3. Zeskind JE, et al.
    A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med 2012; 4: 67. doi:10.1186/gm300
    OpenUrlCrossRefPubMed
  8. ↵
    1. Chen B,
    2. Khodadoust MS,
    3. Liu CL, et al.
    Profiling tumor infiltrating immune cells with CIBERSORT. In: von Stechow L, ed. Cancer Systems Biology. New York, Springer, 2018; pp. 243–259.
  9. ↵
    1. Aliee H,
    2. Massip F,
    3. Qi C
    , et al. Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways. Allergy 2022; 77: 690–694. doi:10.1111/all.15152
    OpenUrl
  10. ↵
    1. Rathnayake SNH,
    2. Hoesein FAAM,
    3. Galban CJ, et al.
    Gene expression profiling of bronchial brushes is associated with the level of emphysema measured by computed tomography-based parametric response mapping. Am J Physiol Lung Cell Mol Physiol 2020; 318: L1222–L1228. doi:10.1152/ajplung.00051.2020
    OpenUrl
  11. ↵
    1. Sauler M,
    2. McDonough JE,
    3. Adams TS
    , et al. Characterization of the COPD alveolar niche using single-cell RNA sequencing. Nat Commun 2022; 13: 494. doi:10.1038/s41467-022-28062-9
    OpenUrl
  12. ↵
    1. Vieira Braga FA,
    2. Kar G,
    3. Berg M, et al.
    A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 2019; 25: 1153–1163. doi:10.1038/s41591-019-0468-5
    OpenUrlCrossRefPubMed
  13. ↵
    1. Curras-Alonso S,
    2. Soulier J,
    3. Walter T, et al.
    Spatial transcriptomics for respiratory research and medicine. Eur Respir J 2021; 58: 2004314. doi:10.1183/13993003.04314-2020
    OpenUrlFREE Full Text
  14. ↵
    1. McDonough JE,
    2. Yuan R,
    3. Suzuki M, et al.
    Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567–1575. doi:10.1056/NEJMoa1106955
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 59 Issue 5 Table of Contents
European Respiratory Journal: 59 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quality over quantity: the importance of collecting relevant samples to understand complex diseases
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Quality over quantity: the importance of collecting relevant samples to understand complex diseases
Alen Faiz, Maarten van den Berge
European Respiratory Journal May 2022, 59 (5) 2200418; DOI: 10.1183/13993003.00418-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Quality over quantity: the importance of collecting relevant samples to understand complex diseases
Alen Faiz, Maarten van den Berge
European Respiratory Journal May 2022, 59 (5) 2200418; DOI: 10.1183/13993003.00418-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • World Pneumonia Day 2023: the rising global threat of pneumonia
  • Cardiopulmonary response to exercise in extreme prematurity
  • ERS “CONNECT” Clinical Research Collaboration
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society